Complement Receptor 1 Variants Confer Protection from Severe Malaria in Odisha, India

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Panda, Aditya K ^a   Panda, Madhumita ^a   Tripathy, Rina ^b   Pattanaik, Sarit S ^b   Ravindran, Balachandran ^a   Das, Bidyut K ^b  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b SCB Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ALLELE; ARTICLE; BLOOD GROUP B; BLOOD GROUP TYPING; BRAIN MALARIA; CASE CONTROL STUDY; CONTROLLED STUDY; CR1 GENE; DATA ANALYSIS; DISEASE SEVERITY; ENDEMIC DISEASE; ERYTHROCYTE; EXON; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; INDIA; INFECTION RESISTANCE; INTRON; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MORTALITY; MULTIPLE ORGAN FAILURE; PREVALENCE; PROGNOSIS;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; INTRONS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PUBLICATION BIAS; RECEPTORS, COMPLEMENT 3B; TREATMENT OUTCOME; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

EID: 84869037909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049420     Document Type: Article

References (40)

1. WHO (2011) World Malaria Report 2011.
2. Panda AK, Panda SK, Sahu AN, Tripathy R, Ravindran B, et al. (2011) Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar J 10: 309.
3. Pattanaik SS, Tripathy R, Panda AK, Sahu AN, Das BK (2012) Bacteraemia in adult patients presenting with malaria in India. Acta Trop.
4. Brown H, Hien TT, Day N, Mai NT, Chuong LV, et al. (1999) Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 25: 331-340.
5. Clark IA, Budd AC, Alleva LM, Cowden WB, (2006) Human malarial disease: a consequence of inflammatory cytokine release. Malar J 5: 85.
6. Clark IA, Alleva LM, (2009) Is human malarial coma caused, or merely deepened, by sequestration? Trends Parasitol 25: 314-318.
7. Rowe JA, Claessens A, Corrigan RA, Arman M, (2009) Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 11: e16.
8. Ringwald P, Peyron F, Lepers JP, Rabarison P, Rakotomalala C, et al. (1993) Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun 61: 5198-5204.
9. Rowe JA, Moulds JM, Newbold CI, Miller LH, (1997) P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388: 292-295.
10. Stoute JA, (2011) Complement receptor 1 and malaria. Cell Microbiol 13: 1441-1450.
11. Roozendaal R, Carroll MC, (2007) Complement receptors CD21 and CD35 in humoral immunity. Immunol Rev 219: 157-166.
12. Stoute JA, Odindo AO, Owuor BO, Mibei EK, Opollo MO, et al. (2003) Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. J Infect Dis 187: 522-525.
13. Sinha S, Jha GN, Anand P, Qidwai T, Pati SS, et al. (2009) CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity. Hum Immunol 70: 244-250.
14. Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, et al. (2004) A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A 101: 272-277.
15. Krych-Goldberg M, Moulds JM, Atkinson JP, (2002) Human complement receptor type 1 (CR1) binds to a major malarial adhesin. Trends Mol Med 8: 531-537.
16. Vik DP, Wong WW, (1993) Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. J Immunol 151: 6214-6224.
17. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, et al. (1986) Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 164: 50-59.
18. Nagayasu E, Ito M, Akaki M, Nakano Y, Kimura M, et al. (2001) CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand. Am J Trop Med Hyg 64: 1-5.
19. Rout R, Dhangadamajhi G, Mohapatra BN, Kar SK, Ranjit M, (2011) High CR1 level and related polymorphic variants are associated with cerebral malaria in eastern-India. Infect Genet Evol 11: 139-144.
20. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG, (1998) Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 87: 176-183.
21. Rowe JA, Raza A, Diallo DA, Baby M, Poudiougo B, et al. (2002) Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility. Genes Immun 3: 497-500.
22. Xiang L, Rundles JR, Hamilton DR, Wilson JG, (1999) Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 163: 4939-4945.
23. Boiocchi C, Zorzetto M, Sbarsi I, Pirotta A, Schirinzi S, et al. (2009) CR1 genotype and haplotype involvement in coronary artery disease: the pivotal role of hypertension and dyslipidemia. Int J Mol Med 24: 181-187.
24. Zorzetto M, Bombieri C, Ferrarotti I, Medaglia S, Agostini C, et al. (2002) Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 27: 17-23.
25. Yuan YD, Zhao MX, Yu J, (2011) [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis]. Zhonghua Jie He He Hu Xi Za Zhi 34: 841-845.
26. Mrazek F, Kvezereli M, Garr E, Kubistova Z, Kriegova E, et al. (2008) Complement receptor 1 single nucleotide polymorphisms in Czech and Dutch patients with sarcoidosis. Tissue Antigens 71: 77-80.
27. Srivastava A, Mittal B, (2009) Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population. Scand J Immunol 70: 614-620.
28. Teeranaipong P, Ohashi J, Patarapotikul J, Kimura R, Nuchnoi P, et al. (2008) A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria. J Infect Dis 198: 1880-1891.
29. Rowe A, Obeiro J, Newbold CI, Marsh K, (1995) Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 63: 2323-2326.
30. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, et al. (2007) Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 104: 17471-17476.
31. Uneke CJ, (2007) Plasmodium falciparum malaria and ABO blood group: is there any relationship? Parasitol Res 100: 759-765.
32. NVBDCP (2004) Government of India Report. Ministry of Health and Family Welfare.
33. NVBDCP (2010) Government of India Report. Ministry of Health and Family Welfare.
34. Dupont WD, Plummer WD Jr, (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19: 589-601.
35. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
36. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
38. Kwiatkowski DP, (2005) How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77: 171-192.
39. Kumar A, Sinha S, Khandekar PS, Banerjee K, Srivastava LM, (1995) Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Immunol Cell Biol 73: 457-462.
40. Egger M, Smith GD, Phillips AN, (1997) Meta-analysis: principles and procedures. BMJ 315: 1533-1537.